Citigroup Inc Prothena Corp Public LTD CO Transaction History

Citigroup Inc

$169 Billion
Q3 2024

A detailed history of Citigroup Inc transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Citigroup Inc holds 32,074 shares of PRTA stock, worth $500,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,074

Previous 24,664 30.04%

Holding current value

$500,995

Previous $509,000 5.3%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$16.73 - $24.79 $123,969 - $183,693	7,410 Added 30.04%	32,074 $536,000
Q2 2024 Aug 12, 2024	SELL	$19.54 - $26.15 $4.6 Million - $6.15 Million	-235,208 Reduced 90.51%	24,664 $509,000
Q1 2024 May 10, 2024	BUY	$24.75 - $40.66 $4.26 Million - $7.01 Million	172,291 Added 196.72%	259,872 $6.44 Million
Q4 2023 Feb 09, 2024	BUY	$32.31 - $52.32 $634,923 - $1.03 Million	19,651 Added 28.93%	87,581 $3.18 Million
Q3 2023 Nov 09, 2023	BUY	$47.3 - $70.6 $963,879 - $1.44 Million	20,378 Added 42.85%	67,930 $3.28 Million
Q2 2023 Aug 10, 2023	SELL	$48.26 - $78.59 $3.25 Million - $5.29 Million	-67,248 Reduced 58.58%	47,552 $3.25 Million
Q1 2023 May 11, 2023	BUY	$46.97 - $58.27 $2.41 Million - $3 Million	51,400 Added 81.07%	114,800 $5.56 Million
Q4 2022 Feb 09, 2023	SELL	$52.05 - $65.0 $1.81 Million - $2.26 Million	-34,744 Reduced 35.4%	63,400 $3.82 Million
Q3 2022 Nov 10, 2022	BUY	$25.16 - $60.63 $321,091 - $773,760	12,762 Added 14.95%	98,144 $5.95 Million
Q2 2022 Aug 10, 2022	BUY	$22.73 - $39.98 $1.36 Million - $2.39 Million	59,797 Added 233.72%	85,382 $2.32 Million
Q1 2022 May 12, 2022	SELL	$30.27 - $49.22 $2.26 Million - $3.68 Million	-74,703 Reduced 74.49%	25,585 $937,000
Q4 2021 Feb 10, 2022	BUY	$42.11 - $73.26 $1.98 Million - $3.44 Million	47,003 Added 88.21%	100,288 $4.95 Million
Q3 2021 Nov 10, 2021	BUY	$48.2 - $78.89 $2.57 Million - $4.2 Million	53,285 New	53,285 $3.8 Million

Others Institutions Holding PRTA

# of Institutions

187

Shares Held

42.8M

Call Options Held

162K

Put Options Held

102K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $733M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account